# Gel Microspheres as Multifunctional Carriers for Photodynamic Therapy: Advancing Hepatocellular Carcinoma Treatment

**Authors:** Shijie Fan, Qiuting Ye, Jieling Lao, Xuanzhuang Wu, Pan Wu, Yongxiang Zhao

PMC · DOI: 10.3390/gels12030214 · 2026-03-05

## TL;DR

This review explores gel microspheres as a promising new approach for treating liver cancer with photodynamic therapy, offering better targeting and fewer side effects.

## Contribution

The paper introduces gel microspheres as a multifunctional platform for photodynamic therapy in hepatocellular carcinoma.

## Key findings

- Gel microspheres enable targeted delivery and controlled release of photosensitizers in the tumor microenvironment.
- They show synergistic effects when combined with chemotherapy, radiotherapy, and immunotherapy.
- Challenges include material parameter control and clinical translation barriers.

## Abstract

Conventional hepatocellular carcinoma (HCC) treatments suffer from insufficient efficacy and severe toxic side effects. This review addresses these issues by focusing on gel microsphere-mediated photodynamic therapy (PDT) as a novel strategy. It outlines the core properties, classifications, and stimulus-responsive mechanisms of gel microspheres, as well as their structure-function compatibility with photosensitizers. The work highlights how gel microspheres enable targeted delivery, tumor microenvironment-responsive release, and synergistic effects with chemotherapy, radiotherapy, and immunotherapy to enhance therapeutic efficacy while reducing off-target damage. Additionally, it discusses current challenges including material parameter controllability and clinical translation hurdles, providing insights for the development of precise and personalized HCC treatments.

## Linked entities

- **Diseases:** hepatocellular carcinoma (MONDO:0007256)

## Full-text entities

- **Genes:** CALR (calreticulin) [NCBI Gene 811] {aka CALR1, CRT, HEL-S-99n, RO, SSA, cC1qR}, Gpt (glutamic pyruvic transaminase, soluble) [NCBI Gene 76282] {aka 1300007J06Rik, 2310022B03Rik, ALT, ALT1, Gpt-1, Gpt1}, HMGB1 (high mobility group box 1) [NCBI Gene 3146] {aka HMG-1, HMG1, HMG3, SBP-1}, Tmprss11d (transmembrane protease, serine 11d) [NCBI Gene 231382] {aka AST, AsP}
- **Diseases:** liver tumor (MESH:D008113), metastasis (MESH:D009362), phototoxicity (MESH:D017484), injury to (MESH:D014947), HCC (MESH:D006528), cytotoxic (MESH:D064420), Tumor (MESH:D009369), Hypoxia (MESH:D000860), hepatic, renal or myelotoxicity (MESH:D058186), swelling (MESH:D004487), necrosis (MESH:D009336), hypoxic (MESH:D002534)
- **Chemicals:** Pluronic F127 (MESH:D020442), disulfide (MESH:D004220), PLA (MESH:C033616), superoxide anion (MESH:D013481), carboxymethyl cellulose (MESH:D002266), PCL (MESH:C016240), chlorophyllin a (MESH:C007020), Oxygen (MESH:D010100), phthalocyanine (MESH:C013647), 1O2 (-), quinone (MESH:C004532), polymer (MESH:D011108), 177Lu (MESH:C000615061), hydrogen (MESH:D006859), lipid (MESH:D008055), hydrazone (MESH:D006835), doxorubicin (MESH:D004317), HA (MESH:D006820), ADP (MESH:D000244), PLGA (MESH:D000077182), PA (MESH:D009757), perfluorocarbons (MESH:D005466), hematoporphyrin (MESH:D006415), chitosan (MESH:D048271), PEG (MESH:D011092), OH (MESH:C031356), protoporphyrin IX (MESH:C028025), GSH (MESH:D005978), PVA (MESH:C063253), radionuclide (MESH:D011868), H2O2 (MESH:D006861), hydroxyl radicals (MESH:D017665), ROS (MESH:D017382), singlet oxygen (MESH:D026082), 5-aminolevulinic acid (MESH:C000614854), DAMP (MESH:C116255), water (MESH:D014867), PS (MESH:D010758), sugar (MESH:D000073893), ATP (MESH:D000255), porphyrin (MESH:D011166), sodium alginate (MESH:D000464), calcium peroxide (MESH:C403632), S (MESH:D013455)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** A2A

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13024968/full.md

---
Source: https://tomesphere.com/paper/PMC13024968